Empliciti

Empliciti (Elotuzumab) is an intravenous medication used in cancer treatment. This monoclonal antibody targets specific proteins to support immune system function.

Empliciti is primarily used in combination with other therapies for the treatment of multiple myeloma, a type of blood cancer. It works by enhancing the immune system's ability to target and destroy cancer cells. Patients often wonder, 'What is Empliciti used for?'—it is designed to help manage this specific form of cancer.

Common effects of Empliciti may include fatigue, fever, and infusion reactions. Some patients experience nausea or muscle pain. These effects can vary widely among individuals.

Empliciti should be administered under medical supervision due to its potent nature. Patients with a history of severe allergic reactions or certain infections should discuss their medical history with their healthcare provider before starting treatment.

Empliciti may interact with other medications, particularly those that affect the immune system. It is important to inform healthcare providers about all current medications, including over-the-counter drugs and supplements, to avoid potential interactions.